DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Naing A, Meric-Bernstam F, Stephen B. et al.
Phase 2 study of pembrolizumab in patients with advanced rare cancers.
J Immunother Cancer 2020;
8: e000347
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.